Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3458 | 1506 | 36.0 | 82% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
111 | 3 | THROMBOSIS RESEARCH//THROMBOSIS AND HAEMOSTASIS//HEMATOLOGY | 71244 |
3458 | 2 | MASPIN//TAFI//THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR | 1506 |
13030 | 1 | TAFI//THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR//CARBOXYPEPTIDASE U | 864 |
21183 | 1 | MASPIN//SERPINB5//ANGLIA RUSKIN IT ARITI | 430 |
33037 | 1 | TIG3//RARRES3//H REV107 | 130 |
36329 | 1 | GYNECOL BREAST//GYNECOL BREAST PATHOL//MYOEPITHELIAL CELL LAYER | 82 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MASPIN | authKW | 3387270 | 14% | 79% | 212 |
2 | TAFI | authKW | 2231737 | 9% | 80% | 138 |
3 | THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR | authKW | 1091101 | 6% | 65% | 83 |
4 | CARBOXYPEPTIDASE U | authKW | 689881 | 2% | 97% | 35 |
5 | THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR TAFI | authKW | 369818 | 2% | 79% | 23 |
6 | METALLOCARBOXYPEPTIDASE | authKW | 243277 | 1% | 67% | 18 |
7 | PROCARBOXYPEPTIDASE U | authKW | 223015 | 1% | 100% | 11 |
8 | SERPINB5 | authKW | 208530 | 1% | 86% | 12 |
9 | TIG3 | authKW | 208530 | 1% | 86% | 12 |
10 | RARRES3 | authKW | 184308 | 1% | 91% | 10 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Hematology | 4998 | 18% | 0% | 272 |
2 | Peripheral Vascular Diseases | 2897 | 13% | 0% | 202 |
3 | Biochemistry & Molecular Biology | 1785 | 31% | 0% | 468 |
4 | Oncology | 1577 | 18% | 0% | 276 |
5 | Cell Biology | 505 | 11% | 0% | 169 |
6 | Pathology | 470 | 6% | 0% | 85 |
7 | Medical Laboratory Technology | 432 | 3% | 0% | 46 |
8 | Biophysics | 204 | 5% | 0% | 80 |
9 | Medicine, Research & Experimental | 124 | 5% | 0% | 69 |
10 | Genetics & Heredity | 63 | 4% | 0% | 63 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | GYNECOL BREAST | 124163 | 1% | 44% | 14 |
2 | SECT GEN EXPT PATHOL | 96592 | 1% | 53% | 9 |
3 | GYNECOL BREAST PATHOL | 96474 | 2% | 18% | 26 |
4 | BIOL FONAMENTAL | 63063 | 1% | 16% | 19 |
5 | MOL CELLULAR PATHOPHYSIOL | 54054 | 1% | 33% | 8 |
6 | THER EUT DIAGNOST ANTIBODIES | 50048 | 1% | 22% | 11 |
7 | CLIN CHEM L25 | 45615 | 0% | 75% | 3 |
8 | MED COLORECTAL DIS | 45615 | 0% | 75% | 3 |
9 | DIAGNOST TRANSLAT | 45146 | 0% | 32% | 7 |
10 | ANGLIA RUSKIN IT ARITI | 40548 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 23211 | 4% | 2% | 67 |
2 | THROMBOSIS AND HAEMOSTASIS | 7009 | 4% | 1% | 59 |
3 | THROMBOSIS RESEARCH | 2955 | 3% | 0% | 39 |
4 | INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES | 2864 | 1% | 1% | 12 |
5 | APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY | 1945 | 1% | 1% | 12 |
6 | BLOOD COAGULATION & FIBRINOLYSIS | 1756 | 1% | 1% | 17 |
7 | JOURNAL OF CANCER | 1719 | 1% | 1% | 8 |
8 | JOURNAL OF BIOLOGICAL CHEMISTRY | 1225 | 7% | 0% | 101 |
9 | MICROBIOLOGY AND IMMUNOLOGY | 622 | 1% | 0% | 12 |
10 | CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS | 596 | 0% | 0% | 7 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MASPIN | 3387270 | 14% | 79% | 212 | Search MASPIN | Search MASPIN |
2 | TAFI | 2231737 | 9% | 80% | 138 | Search TAFI | Search TAFI |
3 | THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR | 1091101 | 6% | 65% | 83 | Search THROMBIN+ACTIVATABLE+FIBRINOLYSIS+INHIBITOR | Search THROMBIN+ACTIVATABLE+FIBRINOLYSIS+INHIBITOR |
4 | CARBOXYPEPTIDASE U | 689881 | 2% | 97% | 35 | Search CARBOXYPEPTIDASE+U | Search CARBOXYPEPTIDASE+U |
5 | THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR TAFI | 369818 | 2% | 79% | 23 | Search THROMBIN+ACTIVATABLE+FIBRINOLYSIS+INHIBITOR+TAFI | Search THROMBIN+ACTIVATABLE+FIBRINOLYSIS+INHIBITOR+TAFI |
6 | METALLOCARBOXYPEPTIDASE | 243277 | 1% | 67% | 18 | Search METALLOCARBOXYPEPTIDASE | Search METALLOCARBOXYPEPTIDASE |
7 | PROCARBOXYPEPTIDASE U | 223015 | 1% | 100% | 11 | Search PROCARBOXYPEPTIDASE+U | Search PROCARBOXYPEPTIDASE+U |
8 | SERPINB5 | 208530 | 1% | 86% | 12 | Search SERPINB5 | Search SERPINB5 |
9 | TIG3 | 208530 | 1% | 86% | 12 | Search TIG3 | Search TIG3 |
10 | RARRES3 | 184308 | 1% | 91% | 10 | Search RARRES3 | Search RARRES3 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BODENSTINE, TM , SEFTOR, REB , KHALKHALI-ELLIS, Z , SEFTOR, EA , PEMBERTON, PA , HENDRIX, MJC , (2012) MASPIN: MOLECULAR MECHANISMS AND THERAPEUTIC IMPLICATIONS.CANCER AND METASTASIS REVIEWS. VOL. 31. ISSUE 3-4. P. 529 -551 | 191 | 85% | 41 |
2 | HEYLEN, E , WILLEMSE, J , HENDRIKS, D , (2011) AN UPDATE ON THE ROLE OF CARBOXYPEPTIDASE U (TAFIA) IN FIBRINOLYSIS.FRONTIERS IN BIOSCIENCE-LANDMARK. VOL. 16. ISSUE . P. 2427 -2450 | 155 | 80% | 7 |
3 | FOLEY, JH , KIM, PY , MUTCH, NJ , GILS, A , (2013) INSIGHTS INTO THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR FUNCTION AND REGULATION.JOURNAL OF THROMBOSIS AND HAEMOSTASIS. VOL. 11. ISSUE . P. 306-315 | 90 | 88% | 20 |
4 | MARX, PF , VERKLEIJ, CJN , SERON, MV , MEIJERS, JCM , (2009) RECENT DEVELOPMENTS IN THROMBIN-ACTIVATABLE FIBRINOLYSIS INHIBITOR RESEARCH.MINI-REVIEWS IN MEDICINAL CHEMISTRY. VOL. 9. ISSUE 10. P. 1165-1173 | 100 | 96% | 7 |
5 | VERCAUTEREN, E , GILS, A , DECLERCK, PJ , (2013) THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR: A PUTATIVE TARGET TO ENHANCE FIBRINOLYSIS.SEMINARS IN THROMBOSIS AND HEMOSTASIS. VOL. 39. ISSUE 4. P. 365 -372 | 86 | 97% | 10 |
6 | LEURS, J , HENDRIKS, D , (2005) CARBOXYPEPTIDASE U (TAFLA): A METALLOCARBOXYPEPTIDASE WITH A DISTINCT ROLE IN HAEMOSTASIS AND A POSSIBLE RISK FACTOR FOR THROMBOTIC DISEASE.THROMBOSIS AND HAEMOSTASIS. VOL. 94. ISSUE 3. P. 471-487 | 127 | 74% | 51 |
7 | DECLERCK, PJ , (2011) THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR.HAMOSTASEOLOGIE. VOL. 31. ISSUE 3. P. 165-+ | 86 | 95% | 10 |
8 | BOFFA, MB , KOSCHINSKY, ML , (2007) CURIOUSER AND CURIOUSER: RECENT ADVANCES IN MEASUREMENT OF THROMBIN-ACTIVATABLE FIBIRINOLYSIS INHIBITOR (TAFI) AND IN UNDERSTANDING ITS MOLECULAR GENETICS, GENE REGULATION, AND BIOLOGICAL ROLES.CLINICAL BIOCHEMISTRY. VOL. 40. ISSUE 7. P. 431-442 | 96 | 87% | 51 |
9 | PLUG, T , MEIJERS, JCM , (2016) STRUCTURE-FUNCTION RELATIONSHIPS IN THROMBIN-ACTIVATABLE FIBRINOLYSIS INHIBITOR.JOURNAL OF THROMBOSIS AND HAEMOSTASIS. VOL. 14. ISSUE 4. P. 633 -644 | 62 | 82% | 4 |
10 | MARX, PF , (2004) THROMBIN-ACTIVATABLE FIBRINOLYSIS INHIBITOR.CURRENT MEDICINAL CHEMISTRY. VOL. 11. ISSUE 17. P. 2335-2348 | 97 | 84% | 29 |
Classes with closest relation at Level 2 |